BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 9707076)

  • 1. A case of hepatocellular carcinoma associated with troublesome hypoglycemia: management by cytoreduction using percutaneous ethanol injection.
    Saigal S; Nandeesh HP; Malhotra V; Sarin SK
    Am J Gastroenterol; 1998 Aug; 93(8):1380-1. PubMed ID: 9707076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clear cell hepatocellular carcinoma: sudden death from severe hypoglycemia.
    Ross JS; Kurian S
    Am J Gastroenterol; 1985 Mar; 80(3):188-94. PubMed ID: 2983534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe hypoglycemia due to poorly differentiated hepatocellular carcinoma.
    Jayaprasad N; Anees T; Bijin T; Madhusoodanan S
    J Assoc Physicians India; 2006 May; 54():413-5. PubMed ID: 16909744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial chemoembolization for palliation of paraneoplastic hypoglycemia in a patient with advanced hepatocellular carcinoma.
    Whitsett M; Lindenmeyer CC; Shaw CM; Civan JM; Fenkel JM
    J Vasc Interv Radiol; 2013 Dec; 24(12):1918-20. PubMed ID: 24267531
    [No Abstract]   [Full Text] [Related]  

  • 5. Percutaneous Ethanol Injection in the treatment of hepatocellular carcinoma in cirrhosis.
    Livraghi T
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1248-53. PubMed ID: 9730383
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatocellular carcinoma with persistent hypoglycemia: successful treatment with corticosteroid and frequent high carbohydrate intake.
    Thipaporn T; Bubpha P; Varaphon V
    J Med Assoc Thai; 2005 Dec; 88(12):1941-6. PubMed ID: 16518997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined percutaneous ethanol injection through liver puncture and transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma].
    Li C; Shi Z; Hao Y
    Zhonghua Zhong Liu Za Zhi; 2001 Nov; 23(6):490-2. PubMed ID: 11859718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Abnormal glucose metabolism--paraneoplastic syndromes--statistics and etiological mechanism].
    Takeda K
    Nihon Rinsho; 1980 Dec; 38(12):4498-505. PubMed ID: 6265664
    [No Abstract]   [Full Text] [Related]  

  • 9. [Palmar fasciitis and paraneoplastic polyarthritis associated with hepatocellular carcinoma].
    Roman S; Tebib J; Scoazec JY; Menard Y; Paliard P; Dumortier J
    Gastroenterol Clin Biol; 2001 Feb; 25(2):203-4. PubMed ID: 11319448
    [No Abstract]   [Full Text] [Related]  

  • 10. [Paraneoplastic syndrome of hepatocellular carcinoma].
    Tagawa K; Uta Y
    Ryoikibetsu Shokogun Shirizu; 1995; (7):453-5. PubMed ID: 8749523
    [No Abstract]   [Full Text] [Related]  

  • 11. Intraperitoneal hemorrhage as a major complication of percutaneous ethanol injection therapy for hepatocellular carcinoma.
    Ohmoto K; Kunieda T; Shibata N; Yamamoto S
    Hepatogastroenterology; 2000; 47(35):1199-202. PubMed ID: 11100310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycemia, the first presenting sign of hepatocellular carcinoma.
    Nikeghbalian S; Bananzadeh A; Yarmohammadi H
    Saudi Med J; 2006 Mar; 27(3):387-8. PubMed ID: 16532104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma.
    Ohnishi K
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1254-8. PubMed ID: 9730384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis.
    Livraghi T
    Hepatogastroenterology; 2001; 48(37):20-4. PubMed ID: 11268965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatoma with severe non-islet cell tumor hypoglycemia.
    Tietge UJ; Schöfl C; Ocran KW; Wagner S; Böker KH; Brabant G; Zapf J; Manns MP
    Am J Gastroenterol; 1998 Jun; 93(6):997-1000. PubMed ID: 9647037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemia, an atypical early sign of hepatocellular carcinoma.
    Sorlini M; Benini F; Cravarezza P; Romanelli G
    J Gastrointest Cancer; 2010 Sep; 41(3):209-11. PubMed ID: 20204540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Paraneoplastic hypoglycemia in liver-cell carcinoma. Nadler Wolfer Elliott syndrome].
    Krönig B; Baas EU
    Dtsch Med Wochenschr; 1973 Feb; 98(7):322-5. PubMed ID: 4119615
    [No Abstract]   [Full Text] [Related]  

  • 19. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
    Tesdal IK; Wikström M; Flechtenmacher C; Filser T; Dueber C
    Cardiovasc Intervent Radiol; 2006; 29(5):778-84. PubMed ID: 16779690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation combined with percutaneous ethanol injection in the treatment of hepatocellular carcinoma and portal vein neoplastic thrombosis.
    Poggi G; Gatti C; Teragni C; Delmonte A; Bernardo G
    Anticancer Res; 2004; 24(4):2419-21. PubMed ID: 15330193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.